Case report: Clinical experience of treating pembrolizumab-induced systemic capillary leak syndrome (SCLS) in one patient with metastatic gastroesophageal junction squamous cell carcinoma

Systemic capillary leak syndrome (SCLS) is a rare and complex adverse effect of immune checkpoint inhibitors (ICIs). The diagnosis of drug-induced SCLS is based on diffuse infusions of exudative fluid into the interstitial areas and the exclusion of other causes. The best management of ICIs-induced...

Descripció completa

Dades bibliogràfiques

Autors principals:	Hua Ni, Xinjia Ding, Shikai Wu, Xuan Jin
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-09-01
Col·lecció:	Pathology and Oncology Research
Matèries:	immune checkpoint inhibitor pembrolizumab adverse effect systemic capillary leak syndrome SCLS
Accés en línia:	https://www.por-journal.com/articles/10.3389/pore.2023.1611330/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!